Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
HCW Biologics Inc
HCWBCurrent price
0.43 USD
-0.017 USD (-3.80%)
Last closed
0.43 USD
Company
www.hcwbiologics.com
ISIN
US40423R1059
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
19 289 950 USD
Yield for 12 month
-73.13 %
1Y
3Y
5Y
10Y
15Y
HCWB
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. The company was incorporated in 2018 and is headquartered in Miramar, Florida. Address: 2929 North Commerce Parkway, Miramar, FL, United States, 33025
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3 USDP/E ratio
–Dividend Yield
–Current Year
+2 841 794 USD
Last Year
+6 722 090 USD
Current Quarter
+618 854 USD
Last Quarter
+1 126 712 USD
Current Year
-574 824 USD
Last Year
+2 586 378 USD
Current Quarter
+50 479 USD
Last Quarter
+371 246 USD
Key Figures HCWB
1 year
3 years
5 years
10 years
EBITDA
-36 577 048 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-70.09 %
PEG Ratio
–
Return On Equity TTM
-344.32 %
Wall Street Target Price
3 USD
Revenue TTM
3 922 670 USD
Book Value
-0.17 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-0.6 %
Dividend Yield
–
Gross Profit TTM
4 099 750 USD
Earnings per share
-1.05 USD
Diluted Eps TTM
-1.05 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics HCWB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History HCWB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation HCWB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6.7191
Price Sales TTM
4.9176
Enterprise Value EBITDA
-3.6253
Price Book MRQ
2.7998
Financials HCWB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HCWB
For 52 weeks
0.4 USD
1.93 USD
50 Day MA
0.52 USD
Shares Short Prior Month
28 052
200 Day MA
0.99 USD
Short Ratio
1.06
Shares Short
24 886
Short Percent
0.13 %
BeatStart